β-tubulin
TUBBproteinβ-tubulin is released from the platelet cytoskeleton during shape change and activation in acute coronary events.
Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencemedium
RationaleMicrotubule cytoskeleton protein; released during platelet activation.
Druggability
DruggableYes
Known drugs / candidates88
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000196230
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I28
C — confounder / Type-II68
A — assay feasibility72
E — evidence strength25
T1DI (composite)5
Specificity differential (R−C)-40.1
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Human genetic evidence
0.565
Open Targets association (myocardial_infarction)
Literature evidence(1)
- Proteomic changes related to "bewildered" circulating platelets in the acute coronary syndrome.Proteomics · 2011 · PMID 21751358 · doi